DLA
ELAN icon

Douglas Lane & Associates’s Elanco Animal Health ELAN Stock Holding History

Douglas Lane & Associates’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64M Sell
2,599,074
-248,078
-9% -$5.74M 0.87% 39
2026
Q1 		$68.1M Sell
2,847,152
-200,940
-7% -$4.91M 0.98% 33
2025
Q4 		$69M Sell
3,048,092
-396,176
-12% -$8.62M 0.95% 33
2025
Q3 		$69.4M Sell
3,444,268
-68,407
-2% -$1.15M 0.97% 34
2025
Q2 		$50.2M Sell
3,512,675
-382,515
-10% -$4.47M 0.73% 57
2025
Q1 		$40.9M Buy
3,895,190
+205,241
+6% +$2.32M 0.6% 67
2024
Q4 		$44.7M Sell
3,689,949
-77,835
-2% -$1.02M 0.63% 67
2024
Q3 		$55.3M Buy
3,767,784
+37,349
+1% +$520K 0.76% 52
2024
Q2 		$53.8M Sell
3,730,435
-179,025
-5% -$2.86M 0.76% 52
2024
Q1 		$63.6M Sell
3,909,460
-17,770
-0.5% -$278K 0.9% 49
2023
Q4 		$58.5M Sell
3,927,230
-40,591
-1% -$460K 0.9% 48
2023
Q3 		$44.6M Buy
3,967,821
+889,295
+29% +$10.3M 0.75% 53
2023
Q2 		$31M Buy
3,078,526
+613,580
+25% +$5.69M 0.5% 74
2023
Q1 		$23.2M Buy
2,464,946
+286,222
+13% +$3.38M 0.39% 90
2022
Q4 		$26.6M Sell
2,178,724
-243,610
-10% -$3.04M 0.45% 82
2022
Q3 		$30.1M Sell
2,422,334
-131,151
-5% -$2.29M 0.56% 71
2022
Q2 		$50.1M Buy
2,553,485
+57,964
+2% +$1.37M 0.85% 46
2022
Q1 		$65.1M Buy
2,495,521
+135,410
+6% +$3.61M 0.92% 41
2021
Q4 		$67M Buy
2,360,111
+118,101
+5% +$3.67M 0.89% 43
2021
Q3 		$71.5M Buy
2,242,010
+61,322
+3% +$2.06M 1.02% 32
2021
Q2 		$75.6M Buy
2,180,688
+454,605
+26% +$15M 1.06% 36
2021
Q1 		$50.8M Buy
1,726,083
+421,004
+32% +$12.9M 0.79% 52
2020
Q4 		$40M Buy
1,305,079
+114,455
+10% +$3.49M 0.67% 58
2020
Q3 		$33.3M Buy
1,190,624
+267,580
+29% +$6.78M 0.66% 56
2020
Q2 		$19.8M Buy
923,044
+313,332
+51% +$6.92M 0.43% 78
2020
Q1 		$13.7M Buy
609,712
+489,240
+406% +$13.4M 0.36% 84
2019
Q4 		$3.55M Buy
+120,472
New +$3.27M 0.07% 112

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Douglas Lane & Associates's ELAN Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Elanco Animal Health (ELAN) stake by 8.7% in Q2 2026, selling an estimated $5.74M and leaving 2,599,074 shares worth $64M. The position accounts for 0.87% of the portfolio, ranked #39.

Douglas Lane & Associates first reported a position in ELAN in Q4 2019 and has held it in 27 quarters since. The position peaked at $75.6M in Q2 2021. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Douglas Lane & Associates held 2,599,074 shares of Elanco Animal Health worth $64M as of Q2 2026.
  • Douglas Lane & Associates sold 248,078 Elanco Animal Health shares in Q2 2026, an estimated $5.74M.
  • Elanco Animal Health made up 0.87% of Douglas Lane & Associates's portfolio in Q2 2026, its #39 holding.
  • Douglas Lane & Associates first reported a position in Elanco Animal Health in Q4 2019 and has held it in 27 quarters since.
  • Douglas Lane & Associates's Elanco Animal Health position peaked at $75.6M in Q2 2021.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.